Co Diagnostics Inc Receivables Turnover Ratio (CODX), from the second quarter 2026 to the second quarter 2025 current and historic results, rankings and more - CSIMarket
CSIMarket
 


Co diagnostics Inc   (NASDAQ: CODX)
 

Co Diagnostics Inc Accounts Receivables Turnover Ratio from the second quarter 2026 to the second quarter 2025

Quarterly Results, Trends, Rankings, Statistics


Co Diagnostics Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the second quarter 2026 to a ratio of 7.58, above the company average. This is a clear sign of healthy business climate in the Medical Equipment & Supplies industry and improving liquidity at their respective customers, during the second quarter 2026. Average receivable collection period, for the Co Diagnostics Inc in Jun 30 2026 quarter, has decreased to 48 days, compared to 69 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 531 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2026 from 3237 to 3746.

What is Receivable Turnover Ratio?
What is Co Diagnostics Inc Selling?


What is Receivable Turnover Ratio?





CODX Receivables Turnover Ratio (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Receivable Change -75.32 % -39.63 % 43.6 % -68.64 % -61.75 %
Y / Y Revenue Change 1.98 % 190.3 % 76.74 % -77.32 % -93.87 %
Receivable Turnover Ratio (TTM) 7.58 5.32 4.19 3.79 6.1
CODX's Total Ranking # 3746 # 3237 # 3462 # 3082 # 3259
Accounts Receivable average collection period days 48 69 87 96 60
Seq. Receivable Change -36.77 % -56.75 % 240.53 % -73.5 % 54.68 %
Seq. Revenue Change 13.82 % -44.7 % 81.54 % -10.76 % 224.02 %


Receivable Turnover Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 176
Healthcare Sector # 532
Overall Market # 3746

Receivable Turnover Ratio Statistics
High Average Low
1.64 0.37 0
(Sep 30 2020)   (Mar 31 2018)






Financial Statements
Co Diagnostics Inc 's Accounts Receivable $ 0 Millions Visit CODX's Balance sheet
Co Diagnostics Inc 's Sales TTM $ 1 Millions Visit CODX's Income Statement
Sources of CODX's Revenues Visit CODX's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
CODX's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
CODX's Growth Rates CODX's Roa CODX's Inventory Turnover Ratio CODX's Dividend Comparisons
CODX's Profitability Ratios CODX's Roi CODX's Asset Turnover Ratio CODX's Dividend Growth
CODX's Valuation Ratios CODX's Roe CODX's Financial Strength Ratios CODX's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Receivable at quarter ending Jun 30 2026
Bioadaptives Inc   35.76 $ 0.026  Millions$ 0.001  Millions
Lifevantage Corp  35.05 $ 180.947  Millions$ 5.162  Millions
Electrocore Inc   34.09 $ 36.527  Millions$ 1.072  Millions
Innovative Eyewear Inc   31.49 $ 3.412  Millions$ 0.108  Millions
Mangoceuticals Inc   31.43 $ 0.315  Millions$ 0.010  Millions
Cv Sciences Inc   31.22 $ 12.066  Millions$ 0.387  Millions
Jaguar Health Inc   30.23 $ 27.815  Millions$ 0.920  Millions
Invo Fertility Inc   30.20 $ 7.531  Millions$ 0.249  Millions
Metagenomi Therapeutics Inc   25.05 $ 13.561  Millions$ 0.541  Millions
Sonida Senior Living Inc   22.59 $ 525.973  Millions$ 23.283  Millions
U S Physical Therapy Inc  22.40 $ 812.203  Millions$ 36.251  Millions
Nutriband Inc   22.15 $ 1.618  Millions$ 0.073  Millions
Ginkgo Bioworks Holdings Inc   20.32 $ 111.863  Millions$ 5.506  Millions
Lineage Cell Therapeutics Inc   20.02 $ 13.083  Millions$ 0.654  Millions
Hims and Hers Health Inc   19.65 $ 2,578.494  Millions$ 131.228  Millions
Lipocine Inc   18.36 $ 1.569  Millions$ 0.085  Millions
Nrx Pharmaceuticals Inc   17.25 $ 3.394  Millions$ 0.197  Millions
Polomar Health Services, Inc.  17.19 $ 3.172  Millions$ 0.185  Millions
Anika Therapeutics Inc   16.70 $ 121.370  Millions$ 7.266  Millions
Vireo Growth Inc.  16.69 $ 511.706  Millions$ 30.659  Millions
Lifemd Inc   16.48 $ 163.363  Millions$ 9.915  Millions
Neuraxis Inc   15.53 $ 5.316  Millions$ 0.342  Millions
Agenus Inc  15.44 $ 132.693  Millions$ 8.595  Millions
Longeveron Inc   15.03 $ 1.187  Millions$ 0.079  Millions
Medicinova Inc   15.02 $ 0.920  Millions$ 0.061  Millions
Voyager Therapeutics Inc   14.71 $ 34.459  Millions$ 2.343  Millions
Halozyme Therapeutics Inc   14.68 $ 1,663.738  Millions$ 113.332  Millions
Dar Bioscience Inc   14.57 $ 1.345  Millions$ 0.092  Millions
Nexgel Inc   14.52 $ 11.810  Millions$ 0.813  Millions
China Pharma Holdings Inc  14.46 $ 3.914  Millions$ 0.271  Millions

Date modified: 2026-09-03T11:39:25+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.